BioSpace News Archive

Photocure ASA reported Hexvix®/Cysview® revenues of NOK 86.7 million in the third quarter of 2021, and EBITDA of NOK -0.2 million, following the continued successful launch in markets previously operated by Ipsen Pharma SAS.

The Alzheimer’s Disease Data Initiative marked one year of transforming how Alzheimer’s disease and related dementias will be treated by significantly increasing access to data from academic institutions, government-sponsored organizations, pharmaceutical companies, and others dedicated to data sharing and collaboration.

Astrotech Corporation now intends to actively pursue strategic and accretive acquisition opportunities.

Greenwich LifeSciences, Inc. announced CEO Snehal Patel will participate in the virtual portion of Jefferies’ Annual London Healthcare Conference held from November 16-19, 2021.

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that new Phase 3 data for molnupiravir, an investigational oral COVID-19 antiviral medicine, will be presented as a late-breaking poster at the American Society of Tropical Medicine and Hygiene 2021 Annual Meeting taking place virtually from Nov. 17-21.

ANGLE plc, a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 22,667 new ordinary shares of £0.10 each in the Company.

GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced US government contracts totaling approximately $1 billion (USD) to purchase sotrovimab.

Anavex Life Sciences Corp. today announced that it will issue financial results for its fiscal year ended September 30, 2021 on Wednesday November 24, 2021 at 4:30 PM EDT.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven”) announced today that NURTEC® ODT (rimegepant) was approved by the Kuwait Ministry of Health for the acute treatment of migraine with and without aura in adults.

Castle Biosciences, Inc. today announced that it has been named in Inc.’s first-annual Best-Led Companies list, a select, data-driven list of the very strongest U.S. firms with revenue of $50 million to $2 billion.